J. Kovacs, Increases in CD4 T Lymphocytes with Intermittent Courses of Interleukin-2 in Patients with Human Immunodeficiency Virus Infection ??? A Preliminary Study, New England Journal of Medicine, vol.332, issue.9, pp.567-575, 1995.
DOI : 10.1056/NEJM199503023320904

J. Kovacs, Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients, Journal of Clinical Investigation, vol.115, issue.8, pp.2139-2148, 2005.
DOI : 10.1172/JCI23196

J. Kovacs, Controlled Trial of Interleukin-2 Infusions in Patients Infected with the Human Immunodeficiency Virus, New England Journal of Medicine, vol.335, issue.18, pp.1350-1356, 1996.
DOI : 10.1056/NEJM199610313351803

Y. Levy, Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial, The Lancet, vol.353, issue.9168, pp.1923-1929, 1999.
DOI : 10.1016/S0140-6736(98)07345-0

J. Kovacs, Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy, European Journal of Immunology, vol.31, issue.5, pp.1351-1360, 2001.
DOI : 10.1002/1521-4141(200105)31:5<1351::AID-IMMU1351>3.0.CO;2-9

Y. Levy, Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection, AIDS, vol.17, issue.3, pp.343-351, 2003.
DOI : 10.1097/00002030-200302140-00008

D. Abrams, Interleukin-2 therapy in patients with HIV infection, The New England journal of medicine, vol.361, pp.1548-1559, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00426386

S. Josefowicz and A. Rudensky, Control of Regulatory T Cell Lineage Commitment and Maintenance, Immunity, vol.30, issue.5, pp.616-625, 2009.
DOI : 10.1016/j.immuni.2009.04.009

R. Setoguchi, S. Hori, T. Takahashi, and S. Sakaguchi, regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization, The Journal of Experimental Medicine, vol.136, issue.5, pp.723-735, 2005.
DOI : 10.1016/S1074-7613(00)80195-8

J. Fontenot, J. Rasmussen, M. Gavin, and A. Rudensky, A function for interleukin 2 in Foxp3-expressing regulatory T cells, Nature Immunology, vol.171, issue.11, pp.1142-1151, 2005.
DOI : 10.1186/gb-2004-5-10-r80

M. Ahmadzadeh and S. Rosenberg, IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients, Blood, vol.107, issue.6, pp.2409-2414, 2006.
DOI : 10.1182/blood-2005-06-2399

H. Zhang, Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells, Nature Medicine, vol.171, issue.11, pp.1238-1243, 2005.
DOI : 10.1016/S0140-6736(00)02293-5

I. Sereti, In vivo expansion of CD4+CD45RO-CD25+ T cells expressing foxP3 in IL-2-treated HIV-infected patients, Journal of Clinical Investigation, vol.115, issue.7, pp.1839-1847, 2005.
DOI : 10.1172/JCI24307DS1

I. Sereti, Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterisation of a novel subset of CD4+/CD25+ T cells, Blood, vol.100, pp.2159-2167, 2002.

W. Liu, T reg cells, The Journal of Experimental Medicine, vol.376, issue.7, pp.1701-1711, 2006.
DOI : 10.1016/S0092-8674(04)00127-8

N. Seddiki, Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells, The Journal of Experimental Medicine, vol.66, issue.7, pp.1693-1700, 2006.
DOI : 10.1002/eji.200425763

I. Sereti, J. Gea-banacloche, M. Kan, C. Hallahan, and H. Lane, Interleukin 2 Leads to Dose-Dependent Expression of the Alpha Chain of the IL-2 Receptor on CD25-Negative T Lymphocytes in the Absence of Exogenous Antigenic Stimulation, Clinical Immunology, vol.97, issue.3, pp.266-276, 2000.
DOI : 10.1006/clim.2000.4929

C. Baecher-allan, E. Wolf, and D. Hafler, MHC Class II Expression Identifies Functionally Distinct Human Regulatory T Cells, The Journal of Immunology, vol.176, issue.8, pp.4622-4631, 2006.
DOI : 10.4049/jimmunol.176.8.4622

M. Miyara, Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor, Immunity, vol.30, issue.6, pp.899-911, 2009.
DOI : 10.1016/j.immuni.2009.03.019

D. Valmori, A. Merlo, N. E. Souleimanian, C. S. Hesdorffer, and M. Ayyoub, A peripheral circulating compartment of natural naive CD4+ Tregs, Journal of Clinical Investigation, vol.115, issue.7, pp.1953-1962, 2005.
DOI : 10.1172/JCI23963

L. Weiss, Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients, Blood, vol.104, issue.10, pp.3249-3256, 2004.
DOI : 10.1182/blood-2004-01-0365

E. Shevach, Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression, Immunity, vol.30, issue.5, pp.636-645, 2009.
DOI : 10.1016/j.immuni.2009.04.010

K. Wing, CTLA-4 Control over Foxp3+ Regulatory T Cell Function, Science, vol.322, issue.5899, pp.271-275, 2008.
DOI : 10.1126/science.1160062

D. Tran, Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures, Blood, vol.113, issue.21, pp.5125-5133, 2009.
DOI : 10.1182/blood-2009-01-199950

R. Wang, Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells, Proceedings of the National Academy of Sciences, vol.106, issue.32, pp.13439-13444, 2009.
DOI : 10.1073/pnas.0901965106

A. Iellem, Regulatory T Cells, The Journal of Experimental Medicine, vol.95, issue.6, pp.847-853, 2001.
DOI : 10.1084/jem.189.12.1993

Q. Li, miR-181a Is an Intrinsic Modulator of T Cell Sensitivity and Selection, Cell, vol.129, issue.1, pp.147-161, 2007.
DOI : 10.1016/j.cell.2007.03.008

I. Sereti, CD4 T cell expansions are associated with increased apoptosis rates of T lymphocytes during IL-2 cycles in HIV infected patients, AIDS, vol.15, issue.14, pp.1765-1775, 2001.
DOI : 10.1097/00002030-200109280-00004

G. Furtado, C. De-lafaille, M. Kutchukhidze, N. Lafaille, and J. , Regulatory T Cell Function, The Journal of Experimental Medicine, vol.162, issue.6, pp.851-857, 2002.
DOI : 10.1038/ni0901-882

A. Thornton, E. Donovan, C. Piccirillo, and E. Shevach, Cutting Edge: IL-2 Is Critically Required for the In Vitro Activation of CD4+CD25+ T Cell Suppressor Function, The Journal of Immunology, vol.172, issue.11, pp.6519-6523, 2004.
DOI : 10.4049/jimmunol.172.11.6519

C. Durier, Long-term effects of intermittent interleukin-2 therapy in chronic HIV-infected patients (ANRS 048???079 Trials)*, AIDS, vol.21, issue.14, pp.1887-1897, 2007.
DOI : 10.1097/QAD.0b013e3282703825

E. Zorn, IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo, Blood, vol.108, issue.5, pp.1571-1579, 2006.
DOI : 10.1182/blood-2006-02-004747

Y. Levy, Enhanced T cell recovery in HIV-1???infected adults through IL-7 treatment, Journal of Clinical Investigation, vol.119, pp.997-1007, 2009.
DOI : 10.1172/JCI38052

URL : https://hal.archives-ouvertes.fr/inserm-00484803

F. Letimier, N. Passini, S. Gasparian, E. Bianchi, and L. Rogge, Chromatin remodeling by the SWI/SNF-like BAF complex and STAT4 activation synergistically induce IL-12R??2 expression during human Th1 cell differentiation, The EMBO Journal, vol.95, issue.5, pp.1292-1302, 2007.
DOI : 10.1038/sj.emboj.7601586

K. Placek, Integration of Distinct Intracellular Signaling Pathways at Distal Regulatory Elements Directs T-bet Expression in Human CD4+ T Cells, The Journal of Immunology, vol.183, issue.12, pp.7743-7751, 2009.
DOI : 10.4049/jimmunol.0803812

URL : https://hal.archives-ouvertes.fr/pasteur-00509466

L. Rogge, Transcript imaging of the development of human T helper cells using oligonucleotide arrays, Nature Genetics, vol.95, issue.1, pp.96-101, 2000.
DOI : 10.1038/75671

B. Jacquelin, Long oligonucleotide microarrays for African green monkey gene expression profile analysis, The FASEB Journal, vol.21, issue.12, pp.3262-3271, 2007.
DOI : 10.1096/fj.07-8271com

URL : https://hal.archives-ouvertes.fr/pasteur-00161248